Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$10.2M
-18.3% from 2023
Prescriptions
6,152
$1,654.58 per claim
Patients
690
706 prescribers
Total spending, 2024
$10.2M
$14,752.18 per patient
Medicare prescription drug plans paid $10.2M for Evotaz in 2024, for 6,152 prescriptions and refills to 690 patients (down 18.3% from 2023). The average cost per claim was $1,654.58.
New York had the highest Medicare cost for Evotaz in 2024: $1.5M for 877 claims, followed by California ($1.3M).
David M Aboulafia, hematology-oncology in Seattle, WA, had the highest Medicare cost for Evotaz in 2024: 124 claims costing $222K.
Evotaz is made by Bristol-Myers Squibb Company (BMY), listed in the Medicare spending data as BMS Primarycare.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| David M Aboulafia Seattle, WA | Hematology-Oncology | 124 | 13 | $222K |
| Michael P Mullen New York, NY | Infectious Disease | 57 | Under 11 | $107K |
| Morgan M Mueller |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 896 | 8,388 | 950 | $14.8M |
| 2023 | 803 | 7,014 | 805 | $12.5M |
| 2024 | 706 | 6,152 | 690 | $10.2M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Physician Assistant |
| 69 |
| Under 11 |
| $106K |
| Vani Gandhi New York, NY | Infectious Disease | 68 | Under 11 | $104K |
| Waref Azmeh Baton Rouge, LA | Infectious Disease | 52 | Under 11 | $84K |
| William T Blake Atlanta, GA | Infectious Disease | 49 | Under 11 | $79K |
| Dana Hughes Nashville, TN | Nurse Practitioner | 40 | Under 11 | $66K |
| Joseph C Gathe Jr. Houston, TX | Infectious Disease | 34 | Under 11 | $64K |
| John P Doweiko Boston, MA | Internal Medicine | 40 | Under 11 | $61K |
| Kehinde A Eguakun Nashville, TN | Nurse Practitioner | 35 | Under 11 | $61K |
| Jeena Mathew Bartow, FL | Nurse Practitioner | 42 | Under 11 | $61K |
| Mary L Eschete Houma, LA | Internal Medicine | 37 | Under 11 | $60K |
| Antonio L Zarraga Milford, DE | Internal Medicine | 35 | Under 11 | $58K |
| John M Quale Brooklyn, NY | Internal Medicine | 36 | Under 11 | $57K |
| Claudette M Johns Fort Pierce, FL | Nurse Practitioner | 35 | Under 11 | $55K |
| Denise L Henderson Jackson, MS | Nurse Practitioner | 37 | Under 11 | $55K |
| Michelle R Salvaggio Oklahoma City, OK | Infectious Disease | 35 | Under 11 | $53K |
| Marcia Alcouloumre Senteno Long Beach, CA | Infectious Disease | 34 | Under 11 | $51K |
| Addi Feinstein Bronx, NY | Infectious Disease | 20 | Under 11 | $48K |
| Linda Ording-Bauer Setauket, NY | Nurse Practitioner | 30 | Under 11 | $47K |
| Rosa O Diring Norfolk, VA | Nurse Practitioner | 27 | Under 11 | $46K |
| Denese C Gomes Richmond, VA | Nurse Practitioner | 27 | Under 11 | $45K |
| Heather C Gibson Spencer, TN | Nurse Practitioner | 24 | Under 11 | $45K |
| Alexander Lafortune Elmhurst, NY | Infectious Disease | 22 | Under 11 | $44K |
| Holly B Walker Jackson, MS | Nurse Practitioner | 29 | Under 11 | $44K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| BMS Primarycare BMY | 6,152 | $10.2M |